GR3034162T3 - Liposome-encapsulated taxol, its preparation and its use - Google Patents
Liposome-encapsulated taxol, its preparation and its useInfo
- Publication number
- GR3034162T3 GR3034162T3 GR20000401857T GR20000401857T GR3034162T3 GR 3034162 T3 GR3034162 T3 GR 3034162T3 GR 20000401857 T GR20000401857 T GR 20000401857T GR 20000401857 T GR20000401857 T GR 20000401857T GR 3034162 T3 GR3034162 T3 GR 3034162T3
- Authority
- GR
- Greece
- Prior art keywords
- pct
- taxol
- liposome
- encapsulated
- sec
- Prior art date
Links
- 229930012538 Paclitaxel Natural products 0.000 title abstract 5
- 229960001592 paclitaxel Drugs 0.000 title abstract 5
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 238000005538 encapsulation Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000000265 homogenisation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4430593A DE4430593C2 (de) | 1994-08-20 | 1994-08-20 | Verfahren zur Herstellung von Liposomal verkapseltem Taxol |
PCT/DE1995/001163 WO1996005821A1 (de) | 1994-08-20 | 1995-08-18 | Liposomal verkapseltes taxol, seine herstellung und seine verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3034162T3 true GR3034162T3 (en) | 2000-11-30 |
Family
ID=6526804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20000401857T GR3034162T3 (en) | 1994-08-20 | 2000-08-09 | Liposome-encapsulated taxol, its preparation and its use |
Country Status (7)
Country | Link |
---|---|
US (1) | US6090955A (el) |
EP (1) | EP0776202B1 (el) |
AT (1) | ATE192924T1 (el) |
DE (3) | DE4447770C2 (el) |
DK (1) | DK0776202T3 (el) |
GR (1) | GR3034162T3 (el) |
WO (1) | WO1996005821A1 (el) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5871898A (en) * | 1997-01-30 | 1998-08-25 | Andaris Limited | Microparticles and their use in cancer treatment |
IT1289939B1 (it) * | 1997-02-20 | 1998-10-19 | Angelini Ricerche Spa | Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua |
US6090407A (en) | 1997-09-23 | 2000-07-18 | Research Development Foundation | Small particle liposome aerosols for delivery of anti-cancer drugs |
US7348025B2 (en) | 1997-09-23 | 2008-03-25 | Research Development Foundation | Small particle liposome aerosols for delivery of anticancer drugs |
US6787132B1 (en) | 1997-12-04 | 2004-09-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Combined chemo-immunotherapy with liposomal drugs and cytokines |
AU756109B2 (en) * | 1997-12-04 | 2003-01-02 | Hadasit Medical Research Services & Development Company Ltd | Methods for antitumor therapy |
US6461637B1 (en) * | 2000-09-01 | 2002-10-08 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
US6146659A (en) * | 1998-07-01 | 2000-11-14 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
US7314637B1 (en) | 1999-06-29 | 2008-01-01 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
DE50008435D1 (de) | 1999-08-06 | 2004-12-02 | Max Delbrueck Centrum | Implantierbares wirkstoffdepot |
FR2797874B1 (fr) * | 1999-08-27 | 2002-03-29 | Adir | Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CN1116875C (zh) * | 2000-10-19 | 2003-08-06 | 南京振中生物工程有限公司 | 紫杉醇脂质组合物及其制备方法 |
WO2002036171A1 (en) | 2000-11-02 | 2002-05-10 | Sloan Kettering Institute For Cancer Research | Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors |
US7115565B2 (en) | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
DE10154464B4 (de) * | 2001-11-08 | 2005-10-20 | Max Delbrueck Centrum | Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol |
EP1506032A1 (en) * | 2002-05-20 | 2005-02-16 | Research Development Foundation | Aerosol drug inhibition of lung metastases |
WO2004002468A1 (en) * | 2002-06-26 | 2004-01-08 | Medigene Oncology Gmbh | Method of producing a cationic liposomal preparation comprising a lipophilic compound |
US20040034336A1 (en) * | 2002-08-08 | 2004-02-19 | Neal Scott | Charged liposomes/micelles with encapsulted medical compounds |
AU2003270102B2 (en) * | 2002-08-23 | 2008-10-02 | Medigene Ag | Non-vesicular cationic lipid formulations |
EA200501252A1 (ru) * | 2003-02-03 | 2006-02-24 | Неофарм, Инк. | Липосомальная композиция, способ ее получения и лекарственное средство на ее основе (варианты) |
US7517342B2 (en) * | 2003-04-29 | 2009-04-14 | Boston Scientific Scimed, Inc. | Polymer coated device for electrically medicated drug delivery |
US20060165744A1 (en) * | 2003-05-22 | 2006-07-27 | Neopharm, Inc | Combination liposomal formulations |
ES2574231T3 (es) * | 2003-10-15 | 2016-06-16 | Syncore Biotechnology Co., Ltd | Uso de liposomas catiónicos que comprenden paclitaxel |
CA2601067A1 (en) | 2005-05-04 | 2006-11-09 | Medigene Ag | Method of administering a cationic liposomal preparation comprising paclitaxel |
PL1888033T3 (pl) * | 2005-06-09 | 2014-09-30 | Meda Ab | Sposób i kompozycja do leczenia chorób zapalnych |
DE102005043706B4 (de) * | 2005-07-02 | 2011-12-01 | Daimler Ag | Rückhaltesystem |
EP1919450B1 (en) * | 2005-09-01 | 2014-06-11 | Meda AB | Antihistamine- and corticosteroid-containing liposome composition and its use for the manufacture of a medicament for treating rhinitis and related disorders |
CA2646156C (en) | 2006-03-22 | 2016-05-24 | Medigene Ag | Treatment of triple receptor negative breast cancer |
US20080108707A1 (en) * | 2006-11-02 | 2008-05-08 | Arbiser Jack L | Antiangiogenic, antitumor, chemopreventative agents |
TWI438009B (zh) * | 2010-02-19 | 2014-05-21 | Teikoku Pharma Usa Inc | 紫杉烷前-乳劑調配物及其製造與使用之方法 |
WO2011139899A2 (en) | 2010-05-03 | 2011-11-10 | Teikoku Pharma Usa, Inc. | Non-aqueous taxane pro-emulsion formulations and methods of making and using the same |
US9066974B1 (en) * | 2010-11-13 | 2015-06-30 | Sirbal Ltd. | Molecular and herbal combinations for treating psoriasis |
US9095606B1 (en) | 2010-11-13 | 2015-08-04 | Sirbal Ltd. | Molecular and herbal combinations for treating psoriasis |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
CN112656764B (zh) * | 2020-12-28 | 2022-09-02 | 吉林大学 | 一种紫杉醇铂类共载靶向长循环脂质体及应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3922193A (en) * | 1992-03-23 | 1993-10-21 | Georgetown University | Liposome encapsulated taxol and a method of using the same |
WO1993025225A1 (en) * | 1992-06-17 | 1993-12-23 | University Of Massachusetts Medical Center | Liposomal formulations for administering to cancer patients |
WO1994026254A1 (en) * | 1993-05-17 | 1994-11-24 | The Liposome Company, Inc. | Incorporation of taxol into liposomes and gels |
US5415869A (en) * | 1993-11-12 | 1995-05-16 | The Research Foundation Of State University Of New York | Taxol formulation |
-
1994
- 1994-08-20 DE DE4447770A patent/DE4447770C2/de not_active Expired - Lifetime
- 1994-08-20 DE DE4430593A patent/DE4430593C2/de not_active Expired - Lifetime
-
1995
- 1995-08-18 US US08/793,238 patent/US6090955A/en not_active Expired - Lifetime
- 1995-08-18 DE DE59508360T patent/DE59508360D1/de not_active Revoked
- 1995-08-18 EP EP95929002A patent/EP0776202B1/de not_active Revoked
- 1995-08-18 AT AT95929002T patent/ATE192924T1/de not_active IP Right Cessation
- 1995-08-18 DK DK95929002T patent/DK0776202T3/da active
- 1995-08-18 WO PCT/DE1995/001163 patent/WO1996005821A1/de not_active Application Discontinuation
-
2000
- 2000-08-09 GR GR20000401857T patent/GR3034162T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0776202B1 (de) | 2000-05-17 |
EP0776202A1 (de) | 1997-06-04 |
DE4447770C2 (de) | 2002-12-19 |
DE4430593C2 (de) | 1999-01-14 |
DE59508360D1 (de) | 2000-06-21 |
DE4430593A1 (de) | 1996-02-22 |
DK0776202T3 (da) | 2000-11-13 |
WO1996005821A1 (de) | 1996-02-29 |
ATE192924T1 (de) | 2000-06-15 |
US6090955A (en) | 2000-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3034162T3 (en) | Liposome-encapsulated taxol, its preparation and its use | |
DE69721766D1 (de) | Neue arzneiformulierung | |
CA2285203A1 (en) | Compositions containing capsaicin or capsaicin analogues and a local anesthetic | |
AR052921A1 (es) | Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica | |
SE9404196D0 (sv) | New antithrombotic formulation | |
PL349028A1 (en) | Cancer treatment composition and method using natural plant essential oils | |
NZ503233A (en) | Synergistic analgesic combination of opioid analgesic and COX-2 inhibitor | |
DE69008476D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose. | |
GR3032673T3 (en) | Use of an effective quantitiy of active substances for the treatment of mixed skin. | |
WO1994008551A3 (en) | Pharmaceutical compositions and methods for treating cold symptoms | |
MX9805705A (es) | Compuestos biaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
SE9701161D0 (sv) | New use I | |
PT1001775E (pt) | Medicamento contendo ioimbina e arginina para tratamento de disfuncao erectil | |
SE9603725D0 (sv) | New teatment | |
ES8707488A1 (es) | Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona | |
IL110289A0 (en) | Pharmaceutical compositions comprising 4'-iodo-4'- deoxydoxorubicin for treating amyloidosis | |
HUT77175A (hu) | Szelegilin alkalmazása epilepsziás betegségek kezelésére használható gyógyszerkészítmények előállítására és szelegilint tartalmazó epilepsziaellenes gyógyszerkészítmények | |
DE59101818D1 (de) | Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung. | |
DE69532560D1 (de) | Anästhetische analgesicte gasmischungen,die enfluran oder isofluran in kombination mit sevofluran oder desfluran enthalten | |
KR900017599A (ko) | 종양 치료용 약학 조성물 | |
EP1011672A4 (en) | CONNECTIONS WITH ANALGETIC EFFECT AND COMPILATIONS THAT CONTAIN THEM | |
UA40974A (uk) | Спосіб лікування міопії у дітей та підлітків | |
IL108283A0 (en) | Use of riluzole for promoting restoration following radiation | |
HK1058305A1 (en) | Combinations of dalfopristine/quinupristine with cefpirome | |
MX9709941A (es) | Nueva composicion farmaceutica con efecto anestesico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MF | Right revoked (revocation) |